CTOs on the Move

PetVivo

www.petvivo.com

 
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.petvivo.com
  • 5251 Edina Industrial Boulevard
    Minneapolis, MN USA 55439
  • Phone: 952.405.6216

Executives

Name Title Contact Details
David Masters
Director of Science and Technology Profile

Similar Companies

Haywood Vocational Opportunities

Haywood Vocational Opportunities is a Hazelwood, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helix Medical Communications

Helix Medical Communications is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Decision Services

Medical Decision Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PhiloMetron Inc

PhiloMetron Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bardy Diagnostics

Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum—over the heart— to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart rhythm which may lead to more clinically actionable diagnoses.